AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2692-9759/189
¹Department of Cardiology, Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey.
2Department of Cardiology, Faculty of Medicine, Hitit University, Corum, Turkey.
*Corresponding Author: Macit Kalçik, Department of Cardiology, Faculty of Medicine, Hit it University, Corum, Turkey.
Citation: Abdülmelik Birgün, Mehmet M. Şahin, Abdullah Sarihan, Ömer B. Çelik, Macit Kalçik. et al., (2026), Ischemia with No Obstructive Coronary Arteries (INOCA): Diagnostic Approaches and Contemporary Treatment Strategies, Cardiology Research and Reports, 8(2); DOI:10.31579/2692-9759/189
Copyright: © 2026, Macit Kalçik. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 21 January 2026 | Accepted: 09 February 2026 | Published: 20 February 2026
Keywords: carcinoid tumor; pulmonary neoplasm; multiple foci
Ischemia with No Obstructive Coronary Arteries (INOCA) is increasingly recognized as a distinct clinical syndrome characterized by objective evidence of myocardial ischemia in the absence of flow-limiting epicardial coronary artery disease. Once considered a benign finding, INOCA is now known to be associated with persistent symptoms, impaired quality of life, recurrent hospitalizations, and adverse cardiovascular outcomes. The condition is highly prevalent among patients undergoing coronary angiography for angina, with a pronounced predominance in women, underscoring important sex specific pathophysiological mechanisms. INOCA encompasses heterogeneous underlying mechanisms, most notably coronary microvascular dysfunction and epicardial coronary vasospasm, which may occur in isolation or coexist. These abnormalities result in dynamic and context dependent ischemia that is frequently missed by conventional diagnostic pathways focused on obstructive coronary disease. As a result, INOCA remains underdiagnosed and undertreated in routine clinical practice. This review provides a comprehensive and contemporary overview of INOCA, integrating current knowledge on its pathophysiology, clinical presentation, diagnostic strategies, and management approaches. We highlight the limitations of traditional anatomy based evaluation and emphasize the importance of functional and mechanism-oriented diagnostic frameworks, including advanced non-invasive imaging and invasive coronary function testing. Particular attention is given to phenotype-guided therapeutic strategies, encompassing targeted anti-ischemic therapy, endothelial and disease modifying treatments, and lifestyle and non-pharmacological interventions. By synthesizing emerging evidence and clinical insights, this review advocates for a multidisciplinary, personalized approach to INOCA. Adoption of mechanism based diagnostic and therapeutic strategies has the potential to improve symptom control, optimize long-term outcomes, and align INOCA management with the principles of modern, patient centered cardiovascular care.
Ischemia with No Obstructive Coronary Arteries (INOCA) describes a clinical syndrome in which patients experience objective evidence of myocardial ischemia despite the absence of significant obstructive epicardial coronary artery disease on coronary angiography. Traditionally, the detection of non-obstructive coronary arteries has often led to reassurance and symptom attribution to non cardiac causes. However, growing evidence challenges this assumption and highlights INOCA as a distinct and clinically relevant cardiovascular entity associated with persistent symptoms, impaired quality of life, and adverse outcomes [1,2].
The terminology surrounding ischemic syndromes without obstructive coronary disease has evolved and can be confusing in clinical practice. INOCA refers specifically to chronic ischemic symptoms or signs in the absence of flow limiting coronary stenoses. ANOCA (Angina with No Obstructive Coronary Arteries) is a symptom based term that emphasizes anginal chest pain without demonstrable ischemia, whereas MINOCA (Myocardial Infarction with No Obstructive Coronary Arteries) describes an acute coronary syndrome phenotype with myocardial injury. Although these entities overlap, INOCA occupies a unique position as a chronic ischemic condition with heterogeneous mechanisms and often elusive diagnostic findings [3,4].
Epidemiologically, INOCA is common. Among patients undergoing coronary angiography for stable angina or suspected ischemic heart disease, a substantial proportion are found to have non-obstructive coronary arteries. This phenomenon is particularly prominent in women, who represent the majority of INOCA cases across multiple clinical settings. Sex specific differences in coronary pathophysiology, hormonal influences, and microvascular function likely contribute to this distribution, underscoring the need for tailored diagnostic and therapeutic approaches [5,6].
A central paradox of INOCA lies in the dissociation between angiographic findings and clinical risk. The absence of obstructive coronary artery disease does not equate to a benign prognosis. Patients frequently experience recurrent angina, repeated hospital admissions, and ongoing functional limitation. Moreover, ischemia in INOCA reflects genuine myocardial supply demand mismatch, often driven by abnormalities at the microvascular or vasomotor level rather than fixed epicardial stenosis [7,8].
Despite its prevalence and clinical impact, INOCA remains underdiagnosed and undertreated. Diagnostic challenges arise from heterogeneous underlying mechanisms, including coronary microvascular dysfunction, epicardial coronary vasospasm, or a combination of both. Conventional diagnostic algorithms centered on obstructive coronary disease frequently fail to identify these abnormalities. Therapeutic uncertainty further compounds the problem, as standardized management strategies are lacking and treatment is often empirical rather than mechanism based [9,10].
The aim of this review is to provide a comprehensive overview of INOCA, integrating current understanding of its pathophysiology, clinical presentation, diagnostic approaches, and contemporary treatment strategies. By emphasizing a structured, mechanism-oriented framework, this review seeks to bridge existing gaps in recognition and management and to support a more personalized approach to patients with ischemia and non-obstructive coronary arteries.
Pathophysiological Mechanisms of INOCA
INOCA is not a single disease entity but rather a clinical syndrome arising from diverse pathophysiological mechanisms that impair myocardial perfusion in the absence of obstructive epicardial coronary artery disease. This heterogeneity explains the wide spectrum of clinical presentations, variable responses to therapy, and frequent diagnostic uncertainty observed in daily practice. Among these mechanisms, coronary microvascular dysfunction (CMD) represents the most prevalent and extensively studied substrate of INOCA (11). The heterogeneous mechanisms underlying INOCA, including coronary microvascular dysfunction, epicardial coronary vasospasm, and mixed phenotypes, along with their typical triggers and diagnostic clues, are summarized in Table 1.
CMD reflects an inability of the coronary microcirculation to appropriately augment blood flow in response to increased myocardial oxygen demand. Because the coronary microvasculature cannot be directly visualized by conventional angiography, functional abnormalities often remain undetected unless specific physiological assessments are performed. Importantly, CMD may occur in isolation or coexist with epicardial vasomotor disorders, further contributing to dynamic and context-dependent ischemia [12].
| Mechanism | Key Pathophysiology | Typical Triggers | Diagnostic Clues | Clinical Phenotype |
| Coronary Microvascular Dysfunction (CMD) | Impaired microvascular vasodilation, increased microvascular resistance, reduced coronary flow reserve | Physical exertion, tachycardia, mental stress | Reduced CFR on PET/CMR/invasive testing, normal epicardial arteries | Effort-related angina, exercise intolerance |
| Epicardial Coronary Vasospasm | Transient focal or diffuse coronary artery spasm due to smooth muscle hyperreactivity | Rest, nocturnal episodes, emotional stress, cold exposure | Ischemic ECG changes during pain, positive acetylcholine test | Rest angina, circadian variation |
| Mixed CMD and Vasospasm | Coexistence of microvascular dysfunction and epicardial spasm | Both exertional and rest-related triggers | Combined abnormalities on invasive testing | Variable symptoms, refractory angina |
| Systemic and Contributing Factors | Endothelial dysfunction, autonomic imbalance, inflammation, hormonal influences | Psychosocial stress, metabolic derangements | No single diagnostic marker; supportive clinical context | Fluctuating, context-dependent ischemia |
Table 1: Pathophysiological Mechanisms of INOCA.
Abbreviations: INOCA: Ischemia with No Obstructive Coronary Arteries, CMD: Coronary Microvascular Dysfunction, CFR: Coronary Flow Reserve, PET: Positron Emission Tomography, CMR: Cardiac Magnetic Resonance, ECG: Electrocardiography
Coronary Microvascular Dysfunction (CMD)
CMD is broadly categorized into structural and functional endotypes. Structural CMD is characterized by anatomical alterations of the microcirculation, including arteriolar wall thickening, capillary rarefaction, and increased microvascular resistance. These changes are frequently associated with chronic cardiovascular risk factors such as hypertension, diabetes mellitus, and left ventricular hypertrophy, leading to persistently reduced coronary flow reserve (CFR) [13].
In contrast, functional CMD primarily reflects abnormal vasomotor regulation without fixed structural remodeling. This phenotype is driven by impaired endothelium dependent and endothelium independent vasodilation, resulting in an inadequate increase in myocardial blood flow during stress. Endothelial nitric oxide bioavailability plays a central role, and its dysfunction contributes to abnormal microvascular tone and heightened ischemic susceptibility [11].
Microvascular remodeling represents a final common pathway in many patients with CMD, linking functional abnormalities to irreversible structural changes over time. Progressive impairment of CFR has been consistently associated with worse clinical outcomes, reinforcing the concept that CMD is not a benign finding but a clinically meaningful determinant of ischemia and prognosis in INOCA [12,13].
Epicardial Coronary Vasospasm
Epicardial coronary vasospasm represents a dynamic and reversible cause of myocardial ischemia in patients with INOCA and is characterized by transient, excessive vasoconstriction of the epicardial coronary arteries. Vasospasm may present as focal spasm, typically localized to a single coronary segment and often associated with atherosclerotic plaques, or as diffuse spasm, which involves long segments of the coronary tree and reflects a more generalized vasomotor disorder (14). These phenotypes have distinct clinical and prognostic implications and may coexist with microvascular dysfunction.
Endothelial dysfunction plays a central role in the pathogenesis of epicardial vasospasm. Impaired bioavailability of nitric oxide leads to a loss of normal vasodilatory responses and a paradoxical vasoconstrictive reaction to stimuli such as acetylcholine. This abnormal endothelial signaling predisposes coronary arteries to hyperreactivity and episodic ischemia, even in angiographically normal vessels [15].
Beyond endothelial nitric oxide dysfunction, activation of the Rho-kinase pathway has emerged as a key molecular mechanism underlying coronary vasospasm. Rho-kinase enhances calcium sensitivity in vascular smooth muscle cells, promoting sustained vasoconstriction independent of intracellular calcium levels. Increased Rho-kinase activity has been demonstrated in patients with vasospastic angina and correlates with disease severity, providing both mechanistic insight and a potential therapeutic target [16]. Collectively, these mechanisms underscore the active and regulated nature of epicardial vasospasm in INOCA rather than a purely functional or incidental phenomenon.
Combined Pathophysiological Mechanisms
In clinical practice, INOCA frequently reflects the coexistence of coronary microvascular dysfunction (CMD) and epicardial coronary vasospasm, rather than a single isolated abnormality. Invasive coronary function testing studies have demonstrated that a substantial proportion of patients exhibit overlapping microvascular impairment and abnormal epicardial vasoreactivity, highlighting the multidimensional nature of ischemia in this population [11,14].
This overlap gives rise to dynamic and context-dependent ischemia, where myocardial perfusion varies according to physiological stress, autonomic tone, circadian influences, or pharmacologic triggers. CMD may dominate during exercise-related ischemia due to impaired coronary flow reserve, whereas vasospastic mechanisms often manifest at rest or during emotional stress, leading to transient but profound reductions in coronary blood flow [12,15]. Such variability explains fluctuating symptoms, inconsistent non-invasive test results, and the frequent mismatch between angiographic findings and clinical burden.
Recognizing combined pathophysiological mechanisms is critical, as integrated diagnostic strategies have been shown to improve symptom control and guide more effective, personalized treatment in INOCA [17].
Systemic and Contributing Factors
Beyond coronary specific abnormalities, systemic factors play a critical modulatory role in the development and expression of ischemia in INOCA. Dysregulation of the autonomic nervous system is increasingly recognized as a contributor, particularly through heightened sympathetic activity and impaired parasympathetic tone. Autonomic imbalance can promote coronary vasoconstriction, amplify microvascular resistance, and precipitate ischemia under physical or emotional stress [12,15].
Inflammation and oxidative stress further exacerbate microvascular and endothelial dysfunction. Chronic low grade inflammation impairs nitric oxide bioavailability, promotes vascular smooth muscle hyperreactivity, and accelerates microvascular remodeling, thereby lowering the ischemic threshold even in the absence of fixed coronary obstruction [11,18].
Hormonal influences, especially fluctuations in estrogen levels, are thought to partially explain the female predominance of INOCA. Estrogen deficiency has been linked to endothelial dysfunction, altered autonomic regulation, and increased vasomotor instability, particularly in postmenopausal women [18].
Finally, metabolic syndrome and insulin resistance contribute to CMD through endothelial dysfunction, inflammation, and impaired microvascular vasodilation. These systemic conditions reinforce the concept of INOCA as a multisystem disorder rather than an isolated coronary phenomenon [13,19].
Clinical Presentation and Risk Profile
Patients with INOCA present with a wide spectrum of symptoms that often differ from those observed in classic obstructive coronary artery disease, contributing to frequent misdiagnosis and delayed recognition. Although typical exertional angina may occur, many patients report atypical chest pain characteristics, including prolonged discomfort, variable intensity, or pain that is poorly responsive to nitrates [19,20]. These features challenge traditional ischemic paradigms that emphasize fixed epicardial stenosis as the primary driver of symptoms.
A hallmark of INOCA is the high prevalence of non–exertional chest pain, frequently occurring at rest or triggered by emotional stress rather than physical activity. Such patterns are particularly common in patients with vasomotor dysfunction and may reflect dynamic changes in coronary tone or autonomic imbalance rather than demand-driven ischemia [17,20]. As a result, standard exercise-based diagnostic algorithms may underestimate disease burden.
Beyond chest pain, dyspnea, fatigue, and exercise intolerance are frequent presenting complaints. These symptoms often dominate the clinical picture and may be disproportionate to findings on coronary angiography or conventional stress testing. Impaired coronary microvascular reserve, abnormal ventricular vascular coupling, and heightened sympathetic activation have all been implicated in limiting functional capacity in INOCA [12,21].
The cardiovascular risk profile of patients with INOCA overlaps substantially with that of obstructive coronary disease. Hypertension, diabetes mellitus, obesity, and smoking are highly prevalent and contribute to endothelial dysfunction and microvascular remodeling [11,13]. Importantly, psychosocial stress plays a prominent role, particularly in women, and has been linked to symptom severity, recurrent healthcare utilization, and reduced quality of life [20,22].
These diverse manifestations give rise to recognizable clinical phenotypes and symptom clusters, including predominantly exertional ischemia, rest-related vasospastic symptoms, and mixed patterns with fluctuating triggers. Appreciating this heterogeneity is essential, as symptom burden and risk cannot be inferred solely from angiographic findings. Instead, INOCA requires a patient-centered assessment that integrates symptom patterns, systemic risk factors, and underlying pathophysiological mechanisms.
Diagnostic Approaches in INOCA
Initial Clinical Evaluation
The diagnostic evaluation of patients with suspected INOCA begins with a comprehensive clinical assessment, as symptom characteristics and baseline risk profile provide critical clues to underlying pathophysiology. A detailed symptom history should extend beyond the presence or absence of exertional chest pain and explore temporal patterns, triggers, duration, response to nitrates, and associations with emotional stress or rest. Such features are particularly important in identifying vasomotor or microvascular ischemia, which often presents with atypical or fluctuating symptom profiles [20,23].
Estimation of pre-test probability of coronary artery disease remains an essential step, although traditional models largely focus on obstructive epicardial disease. In patients with INOCA, pre-test probability tools should be interpreted cautiously, as a low likelihood of obstructive CAD does not exclude clinically relevant ischemia. Contemporary frameworks emphasize integrating age, sex, symptom quality, and cardiovascular risk factors to guide downstream testing while avoiding premature diagnostic closure following a “normal” coronary angiogram [23,24].
Resting electrocardiography (ECG) is routinely performed but is often normal or nonspecific in INOCA. Nonetheless, baseline ECG may reveal repolarization abnormalities, prior silent infarction, or conduction disturbances that influence diagnostic strategy and risk stratification. Importantly, the absence of ischemic changes at rest should not deter further evaluation when symptoms are suggestive [24].
Transthoracic echocardiography (TTE) plays a central role in the initial assessment. While left ventricular systolic function is typically preserved, echocardiography allows exclusion of alternative causes of symptoms such as valvular disease, cardiomyopathies, or pericardial pathology. Subtle findings, including impaired diastolic function, increased left ventricular mass, or abnormal ventricular–vascular coupling, may support a diagnosis of microvascular ischemia and provide prognostic information [21,25]. In selected patients, advanced echocardiographic parameters such as global longitudinal strain may further refine risk assessment.
Overall, meticulous initial clinical evaluation establishes the foundation for targeted diagnostic testing and helps identify patients in whom ischemia persists despite non-obstructive coronary arteries.
Non-Invasive Functional Testing
Non-invasive functional testing is a cornerstone in the evaluation of suspected INOCA, yet each modality has inherent strengths and limitations that must be recognized to avoid false reassurance. Exercise treadmill testing (ETT) remains widely used but has limited sensitivity and specificity in INOCA. Ischemia in this population is often dynamic, non–flow-limiting, or stress-context dependent, leading to frequent false-negative results, particularly in women and patients with microvascular dysfunction [23,26].
Stress echocardiography improves diagnostic yield by assessing inducible wall motion abnormalities and hemodynamic responses. However, because microvascular ischemia may not produce regional contractile abnormalities, stress echocardiography can underestimate ischemic burden in INOCA. Ancillary findings such as abnormal blood pressure response, reduced exercise capacity, or diastolic dysfunction may provide indirect evidence of ischemia despite preserved systolic function [24,27].
Myocardial perfusion imaging plays a central role in detecting functional ischemia. SPECT is widely available and useful for identifying regional perfusion defects, but its spatial resolution and susceptibility to attenuation artifacts limit its ability to detect diffuse microvascular ischemia. As a result, balanced or global reductions in perfusion may be missed [26].
In contrast, PET imaging allows absolute quantification of myocardial blood flow and coronary flow reserve (CFR), making it particularly valuable in INOCA. Reduced CFR on PET provides robust evidence of coronary microvascular dysfunction and carries important prognostic implications, even in the absence of obstructive coronary disease [21,28].
Cardiac magnetic resonance imaging (CMR) has emerged as a powerful modality in INOCA assessment. Stress perfusion CMR offers high spatial resolution and enables detection of subendocardial ischemia typical of microvascular disease. In addition, tissue characterization with late gadolinium enhancement and parametric mapping allows identification of myocardial fibrosis, inflammation, or alternative diagnoses, thereby refining both diagnosis and risk stratification [29].
Overall, optimal non invasive evaluation in INOCA requires thoughtful selection of imaging modalities, with preference for techniques capable of assessing microvascular function rather than relying solely on inducible regional ischemia.
Invasive Coronary Assessment
In patients with persistent symptoms despite non-invasive testing, invasive coronary assessment plays a pivotal role in uncovering the underlying mechanisms of INOCA. Conventional coronary angiography remains essential to exclude flow limiting epicardial stenosis; however, its diagnostic yield is limited when used in isolation. Angiographically “normal” or mildly diseased vessels do not preclude functionally significant ischemia, particularly when abnormalities reside at the microvascular or vasomotor level [23,30]. Invasive physiological assessment enables direct interrogation of coronary function beyond luminal anatomy. Measurement of coronary flow reserve (CFR) provides an integrated index of epicardial and microvascular function, while the index of microcirculatory resistance (IMR) specifically quantifies microvascular resistance independent of hemodynamic conditions. Reduced CFR and/or elevated IMR are hallmark findings of coronary microvascular dysfunction and have been consistently associated with adverse clinical outcomes [30,31].
In contrast, fractional flow reserve (FFR) has a limited role in INOCA. While invaluable for assessing intermediate epicardial stenoses, FFR may be normal in patients with diffuse atherosclerosis or microvascular disease, potentially leading to false reassurance if interpreted without complementary indices [31].Coronary vasoreactivity testing with intracoronary acetylcholine or ergonovine is the gold standard for diagnosing epicardial and microvascular vasospasm. This approach allows differentiation between focal or diffuse epicardial spasm and microvascular spasm based on angiographic response, ischemic symptoms, and electrocardiographic changes. Importantly, vasoreactivity testing is safe when performed in experienced centers and provides actionable diagnostic information that directly guides therapy [14,16,17].
Overall, invasive coronary assessment represents a transformative step in the evaluation of INOCA, shifting the diagnostic paradigm from anatomical exclusion to mechanism-based diagnosis and enabling personalized management strategies.
Diagnostic Algorithms
Given the heterogeneity of INOCA, structured diagnostic algorithms are essential to avoid underdiagnosis and fragmented care. Contemporary guideline based diagnostic pathways emphasize a transition from an anatomy-centered approach toward a function- and mechanism-oriented evaluation. After exclusion of obstructive coronary artery disease, patients with persistent symptoms should undergo targeted functional assessment rather than being reassured based solely on angiographic findings [23,24].
A stepwise evaluation strategy is recommended. Initial clinical assessment and non invasive functional testing help identify patients with objective ischemia or high symptom burden. When non-invasive tests are inconclusive or discordant with symptoms, invasive coronary function testing including assessment of coronary flow reserve, microvascular resistance, and vasoreactivity provides definitive mechanistic classification. This approach enables differentiation between microvascular angina, vasospastic angina, mixed phenotypes, and non-cardiac chest pain, thereby guiding personalized therapy (17,22).
Importantly, the feasibility of these algorithms in real world clinical practice has been demonstrated. While comprehensive invasive testing is not universally available, simplified pathways that integrate symptom profiling, selective advanced imaging, and referral to experienced centers can substantially improve diagnostic accuracy and clinical outcomes. Adoption of standardized diagnostic algorithms represents a critical step toward closing the gap between guideline recommendations and everyday management of patients with INOCA (32,23). A phenotype-based diagnostic and therapeutic framework integrating non-invasive and invasive coronary function testing is outlined in Table 2.
| Dominant Phenotype | Key Diagnostic Findings | Preferred Diagnostic Tests | First-Line Therapy | Drugs to Avoid |
| CMD predominant | Reduced CFR, elevated IMR, absence of epicardial spasm | PET with CFR, stress CMR, invasive CFR/IMR | Beta-blockers, ACEi/ARB, statins, ranolazine | Long-acting nitrates (limited efficacy) |
| Vasospastic Angina | Epicardial spasm with ischemic symptoms and ECG changes | Coronary angiography with acetylcholine testing | High-dose CCBs, long-acting nitrates | Non-selective beta-blockers, triptans |
| Mixed Phenotype | Both CMD and vasospasm present | Comprehensive invasive coronary function testing | Combination therapy (CCB + beta-blocker or ranolazine) | Phenotype-inappropriate monotherapy |
| Unclear / Indeterminate | Persistent symptoms, inconclusive tests | Stepwise escalation, referral to expert centers | Symptom-guided therapy + risk factor control | - |
Table 2: Phenotype-Based Diagnostic and Therapeutic Strategies in INOCA.
Abbreviations: INOCA: Ischemia with No Obstructive Coronary Arteries, CMD: Coronary
Microvascular Dysfunction, CFR: Coronary Flow Reserve, IMR: Index of Microcirculatory Resistance, PET: Positron Emission Tomography, CMR: Cardiac Magnetic Resonance, ECG: Electrocardiography, ACEi: Angiotensin-Converting Enzyme Inhibitors, ARB: Angiotensin Receptor Blockers, CCBs: Calcium Channel Blockers
Prognosis and Clinical Outcomes
INOCA has long been perceived as a benign condition due to the absence of obstructive coronary artery disease; however, accumulating evidence clearly refutes this misconception. Patients with INOCA experience a substantial burden of major adverse cardiovascular events (MACE), recurrent symptoms, and impaired long-term outcomes that rival or, in selected subgroups, approach those observed in obstructive coronary disease [33].
Large observational cohorts have demonstrated that patients with angina and non-obstructive coronary arteries are at increased risk of recurrent hospitalizations driven by persistent chest pain, repeated diagnostic testing, and ongoing therapeutic uncertainty. These recurrent healthcare encounters reflect not only symptom burden but also delayed recognition of the underlying ischemic mechanisms [20,33].
The impact on quality of life is profound. Patients with INOCA frequently report limitations in physical activity, reduced exercise tolerance, and significant psychosocial distress. Importantly, quality-of-life impairment is often disproportionate to angiographic findings and may persist despite reassurance following a “normal” coronary angiogram, highlighting the inadequacy of anatomy based risk assessment alone [19,20].
From a prognostic perspective, long term outcomes are strongly influenced by the underlying endotype. Impaired coronary flow reserve (CFR), a hallmark of coronary microvascular dysfunction, has been consistently associated with increased risk of cardiovascular death and heart failure hospitalization, independent of epicardial disease severity [18,24]. In contrast, patients with predominantly vasospastic phenotypes often experience recurrent ischemic episodes and arrhythmic events but may exhibit more favorable survival when appropriately diagnosed and treated [14,16,35].
These prognostic differences underscore the importance of mechanism based diagnosis in INOCA. Recognition of CMD identifies a subgroup with diffuse vascular disease and higher long term risk, whereas vasospastic angina represents a dynamic but potentially reversible condition when targeted therapy is instituted. Collectively, these data establish INOCA as a clinically meaningful syndrome requiring active risk stratification and longitudinal management rather than diagnostic dismissal. Beyond symptom burden, INOCA is associated with recurrent hospitalizations, major adverse cardiovascular events, and an increased risk of HFpEF, underscoring its prognostic relevance (Figure 1).
Contemporary Treatment Strategies in INOCA
General Treatment Principles
Effective management of INOCA relies on a phenotype guided therapeutic strategy, reflecting the heterogeneity of its underlying mechanisms. Rather than applying uniform antianginal therapy, treatment should be tailored according to the dominant endotype coronary microvascular dysfunction, epicardial vasospasm, or mixed phenotypes identified through functional assessment
[17,36]. This mechanism based approach represents a fundamental shift from anatomy driven care toward precision cardiovascular medicine.
The primary therapeutic objectives are symptom relief and prognostic improvement. Symptom control is critical, as patients with INOCA frequently experience persistent angina, reduced functional capacity, and impaired quality of life despite the absence of obstructive coronary disease. Standard reassurance following a “normal” angiogram is insufficient and may contribute to ongoing morbidity and repeated healthcare utilization [19,20].
Beyond symptomatic benefit, targeted therapy may influence disease trajectory by improving endothelial function, reducing microvascular resistance, and stabilizing coronary vasomotor tone. In particular, recognition of microvascular angina as a distinct clinical entity has facilitated more rational treatment selection and avoidance of ineffective therapies [36]. Concurrently, comprehensive cardiovascular risk factor management including control of blood pressure, glycemic status, lipid levels, and psychosocial stress is essential and should be implemented across all INOCA phenotypes.
Overall, general treatment principles in INOCA emphasize individualized, mechanism oriented care with dual goals of alleviating ischemic symptoms and addressing long term cardiovascular risk.
Anti-Ischemic Pharmacological Therapy
Pharmacological treatment in INOCA should be individualized according to the dominant ischemic mechanism, as drug efficacy varies substantially across phenotypes. Beta blockers are commonly used in patients with coronary microvascular dysfunction, particularly when symptoms are exertional. By reducing heart rate, myocardial oxygen demand, and diastolic filling time mismatch, beta blockers may improve ischemic tolerance in CMD. However, they should be used cautiously in patients with suspected vasospastic angina, where unopposed alpha adrenergic activity may exacerbate spasm [37,38]. Mechanism-specific pharmacological options, their preferred clinical phenotypes, expected benefits, and key limitations are summarized in Table 3.
| Drug Class | Target Mechanism | Best-Suited Phenotype | Expected Benefit | Limitations / Cautions |
| Beta blockers | Reduced heart rate and myocardial oxygen demand | CMD-predominant | Improved exertional angina, exercise tolerance | May worsen vasospasm |
| CCBs | Coronary smooth muscle relaxation | Vasospastic and mixed phenotypes | Prevention of coronary spasm, symptom relief | Hypotension, bradycardia (non-DHP) |
| Nitrates | Vasodilation of large coronary vessels | Vasospastic angina | Relief of rest angina | Limited benefit in CMD, tolerance |
| Ranolazine | Improved myocardial relaxation via late Na⁺ current inhibition | CMD predominant, refractory angina | Reduced angina frequency, improved QoL | QT prolongation, drug interactions |
| Ivabradine | Selective heart rate reduction | CMD with elevated resting HR | Improved diastolic perfusion time | Limited data, bradycardia |
| ACEi / ARBs | Endothelial function improvement | CMD, metabolic comorbidities | Improved CFR, prognostic benefit | Hypotension, renal monitoring |
| Statins | Anti-inflammatory and endothelial effects | All phenotypes | Improved microvascular function, risk reduction | Myopathy, liver enzyme elevation |
Table 3: Pharmacological Therapies in INOCA According to Mechanism
Abbreviations: INOCA: Ischemia with No Obstructive Coronary Arteries, CMD: Coronary Microvascular Dysfunction, CCBs: Calcium Channel Blockers, DHP: Dihydropyridine, Na⁺: Sodium ion, QoL: Quality of Life, HR: Heart Rate, ACEi: Angiotensin-Converting Enzyme Inhibitors, ARBs: Angiotensin Receptor Blockers, CFR: Coronary Flow Reserve.
Calcium channel blockers (CCBs) represent first-line therapy for epicardial coronary vasospasm. Both dihydropyridine and non-dihydropyridine agents effectively reduce vasomotor tone and prevent spontaneous or provoked coronary spasm. CCBs may also provide symptomatic benefit in microvascular angina by improving microvascular vasodilation, making them particularly useful in mixed phenotypes [14,16,38].
Nitrates, while effective in obstructive coronary disease, have important limitations in INOCA. Many patients with microvascular angina report minimal or inconsistent symptom relief, likely due to preferential dilation of larger vessels without meaningful impact on the microcirculation. Long-acting nitrates may be beneficial in vasospastic angina but should be avoided or used cautiously in pure CMD [37].
Ranolazine has emerged as a valuable option for patients with persistent symptoms despite conventional therapy. By inhibiting late sodium current and improving myocardial relaxation, ranolazine may reduce ischemia related to microvascular dysfunction without significant hemodynamic effects. Clinical studies suggest modest but meaningful improvements in angina frequency and quality of life in selected INOCA populations [39].
Ivabradine, through selective heart rate reduction, may improve symptoms in patients with CMD by optimizing diastolic perfusion time. Its role is adjunctive and best suited for patients with elevated resting heart rate who remain symptomatic despite beta blocker or CCB therapy [40].
Endothelial and Disease-Modifying Therapies
In INOCA, endothelial dysfunction represents a central pathophysiological mechanism linking ischemic symptoms to adverse long-term outcomes. Consequently, disease-modifying therapies aimed at improving endothelial function are essential components of management, particularly in patients with coronary microvascular dysfunction.
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) improve endothelial function through multiple mechanisms, including reduction of oxidative stress, attenuation of vascular inflammation, and reversal of microvascular remodeling. Clinical studies in patients with non-obstructive coronary disease have demonstrated improvements in coronary flow reserve and anginal symptoms, supporting their use beyond blood pressure control alone, especially in patients with CMD or metabolic comorbidities [41].
Statins exert pleiotropic vascular effects independent of lipid lowering. By enhancing nitric oxide bioavailability, reducing inflammatory signaling, and stabilizing vascular smooth muscle tone, statins contribute to improved microvascular function. Evidence suggests that statin therapy is associated with improved endothelial-dependent vasodilation and reduced ischemic burden in patients with angina and non-obstructive coronary arteries, reinforcing their role as foundational therapy in INOCA [42].
Finally, anti-inflammatory approaches are increasingly recognized as relevant in INOCA, given the contribution of chronic low-grade inflammation to endothelial dysfunction and microvascular disease. Although large randomized trials specifically targeting inflammation in INOCA are lacking, mechanistic and observational data support inflammation as a modifiable therapeutic target and an important area for future investigation [43].
Management of Vasospastic Angina
The cornerstone of treatment for vasospastic angina is high-dose calcium channel blockers (CCBs), which effectively suppress coronary smooth muscle hyperreactivity and prevent spontaneous or provoked spasm. Both dihydropyridine and non-dihydropyridine CCBs are effective, and combination therapy may be required in refractory cases [38,44].
Long-acting nitrates serve as adjunctive therapy by promoting vasodilation and reducing vasospastic episodes, particularly in patients with nocturnal or rest angina. However, tolerance may develop with chronic use, and nitrates should not replace CCBs as first-line therapy [44,45].
Importantly, several drugs should be avoided in vasospastic angina. Non-selective beta blockers may worsen coronary spasm by unopposed alpha adrenergic activity, and triptans or ergot derivatives can provoke severe vasoconstriction. Recognition of the vasospastic phenotype is therefore essential to prevent iatrogenic exacerbation of ischemia and arrhythmic risk [45].
Lifestyle and Non-Pharmacological Interventions
Lifestyle modification and non-pharmacological strategies play a complementary yet essential role in the management of INOCA. Structured exercise programs improve endothelial function, enhance coronary flow reserve, and reduce symptom burden, particularly in patients with coronary microvascular dysfunction. When delivered within a cardiac rehabilitation framework, exercise training is associated with improved functional capacity, quality of life, and symptom perception, even in the absence of obstructive disease [46].
Given the strong interaction between ischemic symptoms and autonomic tone, stress reduction strategies are particularly relevant. Psychological stress can precipitate ischemia through sympathetic activation and vasomotor instability. Accordingly, psychological interventions, including cognitive behavioral therapy and stress management programs, have demonstrated benefits in symptom control and health-related quality of life, especially in women with INOCA [20,47].
Tailored Therapy Based on Coronary Function Testing
Tailored therapy guided by coronary function testing represents a major advance in the management of INOCA. Stratified treatment strategies that incorporate invasive assessment of coronary flow reserve, microvascular resistance, and vasoreactivity allow precise identification of the dominant ischemic mechanism and selection of targeted therapy. Evidence from randomized studies demonstrates that mechanism-based treatment leads to significant improvements in angina severity, quality of life, and patient satisfaction compared with standard care [17].
The clinical impact of personalized management extends beyond symptom control. By avoiding ineffective therapies and directing treatment toward the underlying pathophysiology, tailored approaches reduce diagnostic uncertainty and recurrent healthcare utilization. These data support the integration of coronary function testing into contemporary care pathways for selected patients with persistent symptoms and suspected INOCA [17].
Special Populations and Emerging Concepts
INOCA disproportionately affects women, who represent the majority of patients presenting with angina and non-obstructive coronary arteries. Sex specific differences in endothelial function, coronary microvascular regulation, hormonal influences, and autonomic balance contribute to this predominance. Women with INOCA frequently experience higher symptom burden, atypical presentations, and greater impairment in quality of life, often leading to delayed diagnosis and under-recognition [20].
An important emerging concept is the association between INOCA and heart failure with preserved ejection fraction (HFpEF). Coronary microvascular dysfunction is increasingly viewed as a shared pathophysiological substrate linking myocardial ischemia to diastolic dysfunction, increased ventricular stiffness, and exercise intolerance. Reduced coronary flow reserve has been shown to predict incident HFpEF and adverse outcomes, suggesting that INOCA and HFpEF may reflect different clinical expressions of systemic microvascular disease [25,48].
The autonomic nervous system plays a key role in modulating coronary vasomotor tone and myocardial perfusion. Heightened sympathetic activation and impaired parasympathetic reserve can precipitate ischemia in the absence of epicardial obstruction, particularly during emotional stress. This mechanism provides a biological link between psychosocial stressors and ischemic symptoms in INOCA [47,49].
Accordingly, mental stress induced ischemia has gained increasing attention, especially in women. Mental stress can provoke ischemia through microvascular constriction, endothelial dysfunction, and inflammatory activation, even when conventional exercise stress testing is normal [47,49].
Finally, emerging biomarkers and novel therapeutic targets are under active investigation. Circulating markers of inflammation, endothelial dysfunction, and microvascular injury, along with advanced imaging-derived phenotypes, may enable earlier diagnosis, refined risk stratification, and more personalized treatment strategies in INOCA [48,50].
Future Directions and Research Gaps
Despite growing recognition of INOCA as a clinically meaningful syndrome, substantial gaps remain in its diagnosis and management. A central unmet need is the standardization of diagnostic criteria across non-invasive and invasive modalities. Variability in definitions of coronary microvascular dysfunction, thresholds for coronary flow reserve, and criteria for vasospastic responses hampers comparability across studies and limits implementation of guideline-recommended pathways in routine practice [42].
Another major limitation is the lack of large, randomized therapeutic trials powered for hard clinical endpoints. Most available evidence derives from small mechanistic studies or observational cohorts, leaving uncertainty regarding the long term prognostic impact of specific pharmacological strategies. This gap underscores the need for multicenter trials evaluating phenotype guided therapy on cardiovascular outcomes rather than symptom relief alone (17,32).
Digital health and remote monitoring represent promising tools to address the fluctuating and context dependent nature of ischemia in INOCA. Wearable sensors, mobile symptom tracking, and home based physiological monitoring may enable real time correlation between symptoms, autonomic tone, and ischemic burden, potentially improving longitudinal management and patient engagement [51]. Advances in artificial intelligence (AI) are poised to transform imaging interpretation and patient phenotyping. AI driven analysis of CMR, PET, and echocardiographic data may uncover subtle microvascular patterns and integrate multimodal datasets to refine diagnosis beyond human pattern recognition [52].
Ultimately, these developments converge toward precision medicine approaches in INOCA. By integrating clinical features, coronary function testing, imaging biomarkers, and digital phenotypes, future care models may deliver individualized risk stratification and targeted therapy, moving beyond anatomy-based paradigms toward truly personalized cardiovascular care [53].
Ischemia with No Obstructive Coronary Arteries represents a distinct and clinically significant cardiovascular syndrome that challenges traditional, anatomy-centered concepts of ischemic heart disease. Accumulating evidence demonstrates that the absence of flow limiting epicardial stenosis does not imply a benign condition. Instead, INOCA encompasses heterogeneous mechanisms, most commonly coronary microvascular dysfunction and epicardial vasospasm, which give rise to persistent ischemic symptoms, impaired quality of life, and increased long-term cardiovascular risk.This review highlights the importance of moving beyond conventional diagnostic pathways that rely solely on coronary angiography. Comprehensive evaluation integrating careful clinical assessment, advanced non-invasive imaging, and selective invasive coronary function testing enables identification of the dominant ischemic mechanism and supports more accurate diagnosis. Such an approach addresses a major source of diagnostic uncertainty and helps avoid inappropriate reassurance or ineffective treatment.
From a therapeutic perspective, management of INOCA should be individualized and mechanism based. Phenotype-guided pharmacological therapy, combined with aggressive cardiovascular risk factor modification and non-pharmacological interventions, offers the greatest potential for symptom relief and meaningful improvement in patient outcomes. Importantly, recognition of INOCA as a chronic condition underscores the need for longitudinal care rather than episodic symptom management.
In daily clinical practice, effective care for patients with INOCA requires a multidisciplinary approach involving cardiologists, imaging specialists, rehabilitation teams, and, when appropriate, behavioral health professionals. Embracing a mechanism based framework not only improves diagnostic accuracy and therapeutic precision but also aligns INOCA management with the principles of contemporary, patient centered cardiovascular medicine.
Contributorship: All of the authors contributed planning, conduct, and reporting of the work. All authors had full access to all data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Funding: No financial funding was received for this study.
Competing interests: All of the authors have no conflict of interest.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
I would like to offer my testimony in the support. I have received through the peer review process and support the editorial office where they are to support young authors like me, encourage them to publish their work in your esteemed journals, and globalize and share knowledge globally. I really appreciate your journal, peer review, and editorial office.
Dear Agrippa Hilda- Editorial Coordinator of Journal of Neuroscience and Neurological Surgery, "The peer review process was very quick and of high quality, which can also be seen in the articles in the journal. The collaboration with the editorial office was very good."
I would like to express my sincere gratitude for the support and efficiency provided by the editorial office throughout the publication process of my article, “Delayed Vulvar Metastases from Rectal Carcinoma: A Case Report.” I greatly appreciate the assistance and guidance I received from your team, which made the entire process smooth and efficient. The peer review process was thorough and constructive, contributing to the overall quality of the final article. I am very grateful for the high level of professionalism and commitment shown by the editorial staff, and I look forward to maintaining a long-term collaboration with the International Journal of Clinical Case Reports and Reviews.
To Dear Erin Aust, I would like to express my heartfelt appreciation for the opportunity to have my work published in this esteemed journal. The entire publication process was smooth and well-organized, and I am extremely satisfied with the final result. The Editorial Team demonstrated the utmost professionalism, providing prompt and insightful feedback throughout the review process. Their clear communication and constructive suggestions were invaluable in enhancing my manuscript, and their meticulous attention to detail and dedication to quality are truly commendable. Additionally, the support from the Editorial Office was exceptional. From the initial submission to the final publication, I was guided through every step of the process with great care and professionalism. The team's responsiveness and assistance made the entire experience both easy and stress-free. I am also deeply impressed by the quality and reputation of the journal. It is an honor to have my research featured in such a respected publication, and I am confident that it will make a meaningful contribution to the field.
"I am grateful for the opportunity of contributing to [International Journal of Clinical Case Reports and Reviews] and for the rigorous review process that enhances the quality of research published in your esteemed journal. I sincerely appreciate the time and effort of your team who have dedicatedly helped me in improvising changes and modifying my manuscript. The insightful comments and constructive feedback provided have been invaluable in refining and strengthening my work".
I thank the ‘Journal of Clinical Research and Reports’ for accepting this article for publication. This is a rigorously peer reviewed journal which is on all major global scientific data bases. I note the review process was prompt, thorough and professionally critical. It gave us an insight into a number of important scientific/statistical issues. The review prompted us to review the relevant literature again and look at the limitations of the study. The peer reviewers were open, clear in the instructions and the editorial team was very prompt in their communication. This journal certainly publishes quality research articles. I would recommend the journal for any future publications.
Dear Jessica Magne, with gratitude for the joint work. Fast process of receiving and processing the submitted scientific materials in “Clinical Cardiology and Cardiovascular Interventions”. High level of competence of the editors with clear and correct recommendations and ideas for enriching the article.
We found the peer review process quick and positive in its input. The support from the editorial officer has been very agile, always with the intention of improving the article and taking into account our subsequent corrections.
My article, titled 'No Way Out of the Smartphone Epidemic Without Considering the Insights of Brain Research,' has been republished in the International Journal of Clinical Case Reports and Reviews. The review process was seamless and professional, with the editors being both friendly and supportive. I am deeply grateful for their efforts.
To Dear Erin Aust – Editorial Coordinator of Journal of General Medicine and Clinical Practice! I declare that I am absolutely satisfied with your work carried out with great competence in following the manuscript during the various stages from its receipt, during the revision process to the final acceptance for publication. Thank Prof. Elvira Farina
Dear Jessica, and the super professional team of the ‘Clinical Cardiology and Cardiovascular Interventions’ I am sincerely grateful to the coordinated work of the journal team for the no problem with the submission of my manuscript: “Cardiometabolic Disorders in A Pregnant Woman with Severe Preeclampsia on the Background of Morbid Obesity (Case Report).” The review process by 5 experts was fast, and the comments were professional, which made it more specific and academic, and the process of publication and presentation of the article was excellent. I recommend that my colleagues publish articles in this journal, and I am interested in further scientific cooperation. Sincerely and best wishes, Dr. Oleg Golyanovskiy.
Dear Ashley Rosa, Editorial Coordinator of the journal - Psychology and Mental Health Care. " The process of obtaining publication of my article in the Psychology and Mental Health Journal was positive in all areas. The peer review process resulted in a number of valuable comments, the editorial process was collaborative and timely, and the quality of this journal has been quickly noticed, resulting in alternative journals contacting me to publish with them." Warm regards, Susan Anne Smith, PhD. Australian Breastfeeding Association.
Dear Jessica Magne, Editorial Coordinator, Clinical Cardiology and Cardiovascular Interventions, Auctores Publishing LLC. I appreciate the journal (JCCI) editorial office support, the entire team leads were always ready to help, not only on technical front but also on thorough process. Also, I should thank dear reviewers’ attention to detail and creative approach to teach me and bring new insights by their comments. Surely, more discussions and introduction of other hemodynamic devices would provide better prevention and management of shock states. Your efforts and dedication in presenting educational materials in this journal are commendable. Best wishes from, Farahnaz Fallahian.
Dear Maria Emerson, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews, Auctores Publishing LLC. I am delighted to have published our manuscript, "Acute Colonic Pseudo-Obstruction (ACPO): A rare but serious complication following caesarean section." I want to thank the editorial team, especially Maria Emerson, for their prompt review of the manuscript, quick responses to queries, and overall support. Yours sincerely Dr. Victor Olagundoye.
Dear Ashley Rosa, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews. Many thanks for publishing this manuscript after I lost confidence the editors were most helpful, more than other journals Best wishes from, Susan Anne Smith, PhD. Australian Breastfeeding Association.
Dear Agrippa Hilda, Editorial Coordinator, Journal of Neuroscience and Neurological Surgery. The entire process including article submission, review, revision, and publication was extremely easy. The journal editor was prompt and helpful, and the reviewers contributed to the quality of the paper. Thank you so much! Eric Nussbaum, MD
Dr Hala Al Shaikh This is to acknowledge that the peer review process for the article ’ A Novel Gnrh1 Gene Mutation in Four Omani Male Siblings, Presentation and Management ’ sent to the International Journal of Clinical Case Reports and Reviews was quick and smooth. The editorial office was prompt with easy communication.
Dear Erin Aust, Editorial Coordinator, Journal of General Medicine and Clinical Practice. We are pleased to share our experience with the “Journal of General Medicine and Clinical Practice”, following the successful publication of our article. The peer review process was thorough and constructive, helping to improve the clarity and quality of the manuscript. We are especially thankful to Ms. Erin Aust, the Editorial Coordinator, for her prompt communication and continuous support throughout the process. Her professionalism ensured a smooth and efficient publication experience. The journal upholds high editorial standards, and we highly recommend it to fellow researchers seeking a credible platform for their work. Best wishes By, Dr. Rakhi Mishra.
Dear Jessica Magne, Editorial Coordinator, Clinical Cardiology and Cardiovascular Interventions, Auctores Publishing LLC. The peer review process of the journal of Clinical Cardiology and Cardiovascular Interventions was excellent and fast, as was the support of the editorial office and the quality of the journal. Kind regards Walter F. Riesen Prof. Dr. Dr. h.c. Walter F. Riesen.
Dear Ashley Rosa, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews, Auctores Publishing LLC. Thank you for publishing our article, Exploring Clozapine's Efficacy in Managing Aggression: A Multiple Single-Case Study in Forensic Psychiatry in the international journal of clinical case reports and reviews. We found the peer review process very professional and efficient. The comments were constructive, and the whole process was efficient. On behalf of the co-authors, I would like to thank you for publishing this article. With regards, Dr. Jelle R. Lettinga.
Dear Clarissa Eric, Editorial Coordinator, Journal of Clinical Case Reports and Studies, I would like to express my deep admiration for the exceptional professionalism demonstrated by your journal. I am thoroughly impressed by the speed of the editorial process, the substantive and insightful reviews, and the meticulous preparation of the manuscript for publication. Additionally, I greatly appreciate the courteous and immediate responses from your editorial office to all my inquiries. Best Regards, Dariusz Ziora
Dear Chrystine Mejia, Editorial Coordinator, Journal of Neurodegeneration and Neurorehabilitation, Auctores Publishing LLC, We would like to thank the editorial team for the smooth and high-quality communication leading up to the publication of our article in the Journal of Neurodegeneration and Neurorehabilitation. The reviewers have extensive knowledge in the field, and their relevant questions helped to add value to our publication. Kind regards, Dr. Ravi Shrivastava.
Dear Clarissa Eric, Editorial Coordinator, Journal of Clinical Case Reports and Studies, Auctores Publishing LLC, USA Office: +1-(302)-520-2644. I would like to express my sincere appreciation for the efficient and professional handling of my case report by the ‘Journal of Clinical Case Reports and Studies’. The peer review process was not only fast but also highly constructive—the reviewers’ comments were clear, relevant, and greatly helped me improve the quality and clarity of my manuscript. I also received excellent support from the editorial office throughout the process. Communication was smooth and timely, and I felt well guided at every stage, from submission to publication. The overall quality and rigor of the journal are truly commendable. I am pleased to have published my work with Journal of Clinical Case Reports and Studies, and I look forward to future opportunities for collaboration. Sincerely, Aline Tollet, UCLouvain.
Dear Ms. Mayra Duenas, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews. “The International Journal of Clinical Case Reports and Reviews represented the “ideal house” to share with the research community a first experience with the use of the Simeox device for speech rehabilitation. High scientific reputation and attractive website communication were first determinants for the selection of this Journal, and the following submission process exceeded expectations: fast but highly professional peer review, great support by the editorial office, elegant graphic layout. Exactly what a dynamic research team - also composed by allied professionals - needs!" From, Chiara Beccaluva, PT - Italy.
Dear Maria Emerson, Editorial Coordinator, we have deeply appreciated the professionalism demonstrated by the International Journal of Clinical Case Reports and Reviews. The reviewers have extensive knowledge of our field and have been very efficient and fast in supporting the process. I am really looking forward to further collaboration. Thanks. Best regards, Dr. Claudio Ligresti
Dear Chrystine Mejia, Editorial Coordinator, Journal of Neurodegeneration and Neurorehabilitation. “The peer review process was efficient and constructive, and the editorial office provided excellent communication and support throughout. The journal ensures scientific rigor and high editorial standards, while also offering a smooth and timely publication process. We sincerely appreciate the work of the editorial team in facilitating the dissemination of innovative approaches such as the Bonori Method.” Best regards, Dr. Matteo Bonori.
I recommend without hesitation submitting relevant papers on medical decision making to the International Journal of Clinical Case Reports and Reviews. I am very grateful to the editorial staff. Maria Emerson was a pleasure to communicate with. The time from submission to publication was an extremely short 3 weeks. The editorial staff submitted the paper to three reviewers. Two of the reviewers commented positively on the value of publishing the paper. The editorial staff quickly recognized the third reviewer’s comments as an unjust attempt to reject the paper. I revised the paper as recommended by the first two reviewers.
Dear Maria Emerson, Editorial Coordinator, Journal of Clinical Research and Reports. Thank you for publishing our case report: "Clinical Case of Effective Fetal Stem Cells Treatment in a Patient with Autism Spectrum Disorder" within the "Journal of Clinical Research and Reports" being submitted by the team of EmCell doctors from Kyiv, Ukraine. We much appreciate a professional and transparent peer-review process from Auctores. All research Doctors are so grateful to your Editorial Office and Auctores Publishing support! I amiably wish our article publication maintained a top quality of your International Scientific Journal. My best wishes for a prosperity of the Journal of Clinical Research and Reports. Hope our scientific relationship and cooperation will remain long lasting. Thank you very much indeed. Kind regards, Dr. Andriy Sinelnyk Cell Therapy Center EmCell
Dear Editorial Team, Clinical Cardiology and Cardiovascular Interventions. It was truly a rewarding experience to work with the journal “Clinical Cardiology and Cardiovascular Interventions”. The peer review process was insightful and encouraging, helping us refine our work to a higher standard. The editorial office offered exceptional support with prompt and thoughtful communication. I highly value the journal’s role in promoting scientific advancement and am honored to be part of it. Best regards, Meng-Jou Lee, MD, Department of Anesthesiology, National Taiwan University Hospital.
Dear Editorial Team, Journal-Clinical Cardiology and Cardiovascular Interventions, “Publishing my article with Clinical Cardiology and Cardiovascular Interventions has been a highly positive experience. The peer-review process was rigorous yet supportive, offering valuable feedback that strengthened my work. The editorial team demonstrated exceptional professionalism, prompt communication, and a genuine commitment to maintaining the highest scientific standards. I am very pleased with the publication quality and proud to be associated with such a reputable journal.” Warm regards, Dr. Mahmoud Kamal Moustafa Ahmed
Dear Maria Emerson, Editorial Coordinator of ‘International Journal of Clinical Case Reports and Reviews’, I appreciate the opportunity to publish my article with your journal. The editorial office provided clear communication during the submission and review process, and I found the overall experience professional and constructive. Best regards, Elena Salvatore.
Dear Mayra Duenas, Editorial Coordinator of ‘International Journal of Clinical Case Reports and Reviews Herewith I confirm an optimal peer review process and a great support of the editorial office of the present journal
Dear Editorial Team, Clinical Cardiology and Cardiovascular Interventions. I am really grateful for the peers review; their feedback gave me the opportunity to reflect on the message and impact of my work and to ameliorate the article. The editors did a great job in addition by encouraging me to continue with the process of publishing.
Dear Cecilia Lilly, Editorial Coordinator, Endocrinology and Disorders, Thank you so much for your quick response regarding reviewing and all process till publishing our manuscript entitled: Prevalence of Pre-Diabetes and its Associated Risk Factors Among Nile College Students, Sudan. Best regards, Dr Mamoun Magzoub.
International Journal of Clinical Case Reports and Reviews is a high quality journal that has a clear and concise submission process. The peer review process was comprehensive and constructive. Support from the editorial office was excellent, since the administrative staff were responsive. The journal provides a fast and timely publication timeline.
Dear Maria Emerson, Editorial Coordinator of International Journal of Clinical Case Reports and Reviews, What distinguishes International Journal of Clinical Case Report and Review is not only the scientific rigor of its publications, but the intellectual climate in which research is evaluated. The submission process is refreshingly free of unnecessary formal barriers and bureaucratic rituals that often complicate academic publishing without adding real value. The peer-review system is demanding yet constructive, guided by genuine scientific dialogue rather than hierarchical or authoritarian attitudes. Reviewers act as collaborators in improving the manuscript, not as gatekeepers imposing arbitrary standards. This journal offers a rare balance: high methodological standards combined with a respectful, transparent, and supportive editorial approach. In an era where publishing can feel more burdensome than research itself, this platform restores the original purpose of peer review — to refine ideas, not to obstruct them Prof. Perlat Kapisyzi, FCCP PULMONOLOGIST AND THORACIC IMAGING.
Dear Grace Pierce, International Journal of Clinical Case Reports and Reviews I appreciate the opportunity to review for Auctore Journal, as the overall editorial process was smooth, transparent and professionally managed. This journal maintains high scientific standards and ensures timely communications with authors, which is truly commendable. I would like to express my special thanks to editor Grace Pierce for his constant guidance, promt responses, and supportive coordination throughout the review process. I am also greatful to Eleanor Bailey from the finance department for her clear communication and efficient handling of all administrative matters. Overall, my experience with Auctore Journal has been highly positive and rewarding. Best regards, Sabita sinha
Dear Mayra Duenas, Editorial Coordinator of the journal IJCCR, I write here a little on my experience as an author submitting to the International Journal of Clinical Case Reports and Reviews (IJCCR). This was my first submission to IJCCR and my manuscript was inherently an outsider’s effort. It attempted to broadly identify and then make some sense of life’s under-appreciated mysteries. I initially had responded to a request for possible submissions. I then contacted IJCCR with a tentative topic for a manuscript. They quickly got back with an approval for the submission, but with a particular requirement that it be medically relevant. I then put together a manuscript and submitted it. After the usual back-and-forth over forms and formality, the manuscript was sent off for reviews. Within 2 weeks I got back 4 reviews which were both helpful and also surprising. Surprising in that the topic was somewhat foreign to medical literature. My subsequent updates in response to the reviewer comments went smoothly and in short order I had a series of proofs to evaluate. All in all, the whole publication process seemed outstanding. It was both helpful in terms of the paper’s content and also in terms of its efficient and friendly communications. Thank you all very much. Sincerely, Ted Christopher, Rochester, NY.
